Details for 2020707826

Up to date per 05.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE KOMBINATION MIT TNO155 UND EINEM PD-1-INHIBITOR

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020707826

EP Publication Number

3923940

E-Number

1862925

Language

PCT Number

IB20051030

Publication Date

22.12.2021 A

03.12.2025 B1

Registration Date

03.12.2025

AT Publication Date

15.12.2025

Application Date

10.02.2020

Registration Number

Priorities

12.02.2019

201962804707 P

IPC

A61K 31/497 20060101AFI20250605BHEP

Maximum Duration of Protection

10.02.2040

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

No representatives present

Inventor

CHEN, Ying-nan Pan130 Odyssey Drive Wilmington, Delaware 19808US

HAO, HuaixiangNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

LIU, ChenNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

MOHSENI, MorvaridNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

HASTINGS, William D.Novartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, MA 02139US

GOLDONI, Silvia1 Wildwood Street Winchester, MA 01890US

Information about Fees